https://www.selleckchem.com/products/bai1.html
Loss of efficacy (LOE) is a well-known phenomenon associated with spinal cord stimulation (SCS) and is the leading cause of explant. Although recent advances in neuromodulation have resulted in a decreased incidence of LOE, it still occurs. Intuition suggests that when LOE ensues, switching to a different SCS therapy/platform could potentially be a viable clinical option; however, there are no data presently available to validate this theory. The primary objective was to evaluate the efficacy of SCS therapy rotation with DeRidder Burst on
Like
Comment
Share
